Search Results for 'Biologics, Proteins, Vaccines'
Contract Service Directory Companies
View All Buyers Guide Companies »
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Catalent Completes RheinCell Therapeutics Acquisition
Plans to facilitate accelerated access to high-quality iPSC banks with integrated solutions from plasmid DNA manufacturing to clinical supply.08.04.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi to Acquire Translate Bio for $3.2B
Upgrades drug formulation capabilities and accelerates development of licensed programs in vaccines and potential to explore other therapeutic areas.08.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Global Cell & Gene Therapy Mfg. Market Could Reach $57.4B by 2028
Market estimated to grow at CAGR of 20% from 2021 to 2028 due to an exponential rise in clinical pipeline along with rising number of regulatory approvals.07.30.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CellCAN and CCRM Partner to Launch CATTI
New Institute will tackle gaps in training Canada’s GMP workforce.07.29.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Akston Biosciences, Seppic Ink Commercial Supply Agreement
Deal is for an adjuvant to formulate shelf-stable COVID-19 vaccine at global scale.07.29.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
ValenzaBio, ProBioGen Enter Cell Line Pact
Aims to maximize cell line productivity leveraging ProBioGen's GlymaxX technology for ValenzaBio's clinical-stage antibody.07.28.21
-
Biologics, Proteins, Vaccines | Drug Development
AAV-Mediated Gene Therapy: Quantifying Viral Titer and Integrity
Droplet Digital PCR offers precise potency data, critical for the proper dosing of gene therapies.Mark White and Marwan Alsarraj , Digital Biology Group at Bio-Rad 07.27.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
Alloy Therapeutics, Echo Investment Capital Create Wheeler Bio
New company set up to accelerate the development of new antibody therapeutics.07.27.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Capsida Unveils Next-Generation Gene Therapy Manufacturing
New 15,000 square foot facility in Thousand Oaks will enable end-to-end gene therapy manufacturing capability.07.27.21
-
Biologics, Proteins, Vaccines | Drug Development | Reader Showcase
Thermo Fisher Scientific Launches Heracell Vios CR CO2 Incubator
First-in-market CO2 incubator combines optimal cell growth capabilities with certified cleanroom compatibility.07.21.21
-
Bioanalytical Services | Biologics, Proteins, Vaccines | Filtration & Purification | QA/QC | Reader Showcase
MOBILion Launches MOBIE HRIM for Biotherapeutic Drug Development
Designed to address characterization challenges during biopharmaceutical drug development and quality monitoring.07.21.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Pfizer, BioNTech Partner with Biovac for COVID-19 Vax in Africa
Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network.07.21.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Catalent Plans $100M Expansion of Biologics Mfg. Capabilities in Italy
Initial phase includes installation of two 2,000-liter single-use bioreactors and associated investments to support early-and late-phase clinical development.07.21.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Eisai, Biogen’s Lecanemab Gets Breakthrough Designation in AD
Based on pre-specified analysis showing consistent reduction of clinical decline across several clinical and biomarker endpoints at the highest doses.07.20.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
Intravacc's Inactivated Polio Vaccine Out-licensed to Sinovac
Sinovac's Eupolio vaccine (sIPV) receives market authorization from the NMPA in China.07.20.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Preclinical Outsourcing
Lonza, CN Bio Partner on Prevalidated Hepatocytes for Organ-on-a-chip Range
Lonza will supply cells to be prequalified for use in CN Bio’s innovative PhysioMimix OOC range of Single- and Multi-Organ Microphysiological Systems.07.19.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
BioNTech to Acquire Kite’s TCR Cell Therapy Platform and Mfg. Facility
Strengthens cell therapy pipeline with individualized solid tumor Neoantigen TCR cell therapy R&D program and adds manufacturing footprint in North America.07.19.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Industry News
GentiBio, Forge Biologics Ink Development and Manufacturing Agreement
Partnership to support GentiBio’s cell therapy pipeline with AAV process development, scale up and GMP manufacturing services.07.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News | Parenterals
Batavia Manufactures IAVI’s Lassa Fever Vax Candidate
Uses innovative 'scale-X' bioreactor to support Phase I clinical trials.07.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Ashfield Launches Cell & Gene Therapy Commercialization Network
EmerGENE is designed to support small and midsize biotechs with the commercialization of their discoveries.07.14.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Curia to Acquire US-based LakePharma
Expanding end-to-end R&D capabilities and scale for biologics.07.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Formulation Development | Industry News | Lyophilization
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Information Technology
I-Mab Expands Next-Gen Novel Oncology Portfolio
Expands pipeline of antibody assets leveraging cutting-edge mRNA and AI technology platforms.07.09.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News
Batavia to Develop Clinical Process for RocketVax’s COVID-19 Vaccine
After successful completion, Batavia will continue to scale-up and optimize the process for commercial scale.07.08.21
-
Biologics, Proteins, Vaccines | cGMP Manufacture
Can mRNA Facilities Really be Flexible?
Four key questions to accommodate growth and expansion.Jeff Heil, PE , Novel Therapy SME, DPS Group Global 07.08.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Fill/Finish | Industry News | Parenterals
Recipharm to Build New Fill-Finish Facility in Morocco
Investment of around $500M by the Moroccan Government to establish capacity and capability for the manufacturing of vaccines and biotherapeutics.07.06.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Cytotoxics and High Potency Manufacturing | Industry News
Novasep, Exelixis Ink ADC Manufacturing Agreement
Covers the cGMP clinical manufacturing of a next-generation ADC drug candidate.07.06.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
AGC Biologics to Acquire Novartis Facility in Longmont, CO
Significantly expands cell and gene therapy capabilities and offerings.07.02.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Fujifilm Invests $850M to Expand Biologics Capabilities
Investment in CDMO business to add development and manufacturing capacity in US and UK.07.01.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Sanofi Launches Dedicated mRNA Vaccines CoE
Approximately €400million investment annually aims to accelerate end-to-end R&D of next-generation vaccines.06.30.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Rentschler Expands Complex Antibodies Production in Germany
Expands capacity with 2,000-liter bioreactor to address increasing demand for complex antibodies.06.30.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
AskBio’s Gene Therapy Program Gets Fast Track Designation
LION-101 is a recombinant adeno-associated virus based vector being developed as a one-time intravenous infusion for Limb-Girdle Muscular Dystrophy Type 2I/R9.06.28.21
-
Analytical Services | Biologics, Proteins, Vaccines | Extractables and Leachables
On-Demand Lab Open House
Sign up to get a close-up look at our US network of laboratories and hear about our expansion plans.
-
Analytical Services | Bioassay Development | Biologics, Proteins, Vaccines | Drug Development
Host Cell Impurities, Bioassays, Micro-Flow Imaging
WHO, FDA and the European Pharmacopoeia have established strict regulatory guidelines to guarantee product quality in biologics.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility
First phase will see the construction of a 25,000 square feet site including a process development lab expansion.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News | Process Development
Catalent to Acquire RheinCell Therapeutics
Strengthens path towards industrialization of induced pluripotent stem cell-based therapies.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate
Complete production and quality assurance of the plasmids to be used in the GMP production of CG01.06.25.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Senti Bio Invests in Cell Therapy Manufacturing Facility
92,000 square-foot cGMP facility will be designed to support clinical and commercial-scale production of allogeneic CAR-NK cell pipeline.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Frontera Therapeutics Starts GMP Manufacturing Facility Construction
Designed for clinical manufacturing and initial commercial manufacturing of rAAV gene therapy products.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Discovery | Facilities | Industry News
AbCellera to Build Antibody Manufacturing Facility in Canada
130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.06.23.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
Danaher To Acquire Aldevron for $9.6B
Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.06.21.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Eisai, BMS Enter Global Anticancer ADC Alliance
BMS to pay as much as $2.45B to co-develop Eisai’s MORAb-20206.18.21
-
Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Sanofi Invests $425M in Flu Vaccine Manufacturing Facility
Newly licensed U.S. manufacturing facility to increase availability of Fluzone High-Dose Quadrivalent.06.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News
AbSci Acquires Cell Therapy Company Totient
Combination of Totient technology with AbSci's platform provides framework and data to enable in silico targeted drug design.06.17.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
Dendreon Pharmaceuticals Establishes Contract Manufacturing Division
Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.06.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
Ocugen, Jubilant Enter COVID-19 Vaccine Partnership
Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.06.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
VERAXA and Quadira Enter ADC Development Partnership
To develop a suite of novel ADCs for the treatment of oncological conditions.06.15.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Yposkesi to Build Second Commercial Bioproduction Site
Creates a new global resource for cell & gene therapy with production capacity for early clinical to commercially available biologics.06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Trials & Filings
Novavax COVID-19 Vax is 90% Effective in Phase 3 Trial
NVX-CoV2373 demonstrates 100% protection against moderate and severe disease, 90% efficacy overall, and met the primary endpoint.06.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
iTeos Therapeutics, GSK Enter Monoclonal Antibody Alliance
GSK now has a leading portfolio of antibodies targeting the CD226 axis, a key target for next-gen immuno-oncology therapies06.14.21
